501 filings
Page 11 of 26
8-K
ukopenx4h0e5idi4nf8a
6 Apr 16
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
12:00am
RW
fovryt0h7 tku2w
6 Apr 16
Registration withdrawal request
12:00am
425
24b 740bl
5 Apr 16
Business combination disclosure
12:00am
UPLOAD
lyg8v709
1 Apr 16
Letter from SEC
12:00am
425
xh6 oyrfx4
30 Mar 16
Business combination disclosure
12:00am
DEFA14A
94zb2n
25 Mar 16
Additional proxy soliciting materials
12:00am
8-K
e5sf9fbw
16 Mar 16
Regulation FD Disclosure
12:00am
NO ACT
lnr03 3r6ta
15 Mar 16
No action letter
12:00am
425
6ispy
4 Mar 16
Business combination disclosure
12:00am
425
ewzoq5lv
24 Feb 16
Business combination disclosure
12:00am
425
ogc89bd1uw2
23 Feb 16
Business combination disclosure
12:00am
425
5srmsxr ow
23 Feb 16
Business combination disclosure
12:00am
8-K
8qnglq7 mjk4do
22 Feb 16
Results of Operations and Financial Condition
12:00am
425
jclsj7mw7tskic
16 Feb 16
Business combination disclosure
12:00am
8-K
mam2yt1xeicqisr
12 Feb 16
Pfizer Names Executive Leadership Team For Combined Organization
12:00am